Abstract
About half of the patients with paraneoplastic diseases develop an immune response against neuronal antigens expressed by both the tumor and the nervous system. In 31 patients with anti-Hu antibodies and 19 patients with anti-Yo antibodies, we searched for the presence of additional non-neuronal auto-antibodies and further studied whether the presence of such auto-antibodies was correlated with a specific oncological or neurological presentation. Positive antinuclear antibodies (ANA) were found at a titer of 1:40 or above in 48% patients with anti-Hu antibodies, and in 37% patients with anti-Yo antibodies. Anti-cytoplasmic antibodies were also detected in 42% patients with anti-Yo antibodies. No specific correlation between the presence of non-neuronal auto-antibodies and clinical characteristics of the patients could be identified. In particular, neither the type of underlying cancer, the overall survival, the tumor response to treatment, nor the neurological presentation were related to the serological status.
Similar content being viewed by others
References
JB Posner JO Dalmau (2000) ArticleTitleParaneoplastic syndromes of the nervous system Clin Chem Lab Med 38 117–122
AF Carpentier B Chassande Z Amoura B Benyahia JC Piette JY Delattre (2001) ArticleTitleSystemic lupus erythematosus with anti-Hu antibodies and polyradiculoneuropathy Neurology 57 558–559
EM Tan TE Feltkamp JS Smolen B Butcher R Dawkins MJ Fritzler T Gordon JA Hardin JR Kalden RG Lahita RN Maini JS McDougal NF Rothfield RJ Smeenk Y Takasaki A Wiik MR Wilson JA Koziol (1997) ArticleTitleRange of antinuclear antibodies in ‘healthy’ individuals Arthritis Rheum 40 1601–1611
JW Moll H Hooijkaas BC Goorbergh Particlevan LG Roos SC Henzen-Logmans CJ Vecht (1996) ArticleTitleSystemic and anti-neuronal auto-antibodies in patients with paraneoplastic neurological disease J Neurol 243 51–56
PA Silburn JC Neil SK Khoo B Daunter R Hill RJ Collins EV Mackay (1984) ArticleTitleImmune complexes in ovarian cancer: Association between IgM class complexes and antinuclear autoantibodies in ascitic fluid Int Arch Allergy Appl Immunol 174 63–66
F Fernandez-Madrid PJ Vord ParticleVan de X Yang RL Karvonen PM Simpson MJ Kraut JL Granda JE Tomkiel (1999) ArticleTitleAntinuclear antibodies as potential markers of lung cancer Clin Cancer Res 5 1393–1400
B Benyahia Z Amoura A Rousseau C Clanche ParticleLe A Carpentier JC Piette JY Delattre (2003) ArticleTitleParaneoplastic antineuronal antibodies in patients with systemic autoimmune diseases J Neurooncol 62 349–351
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aguirre-Cruz, L., Charuel, JL., Carpentier, A.F. et al. Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases. J Neurooncol 71, 39–41 (2005). https://doi.org/10.1007/s11060-004-4536-3
Issue Date:
DOI: https://doi.org/10.1007/s11060-004-4536-3